June 5, 2019

Otsuka Chemical Succeeded Part of the Cefixime Business from Astellas Pharma

TOKYO–(BUSINESS WIRE)–Otsuka Chemical Co., Ltd. (Head office: Chuo-Ku, Osaka; President & Representative Director: Takeharu Harashima; hereinafter “Otsuka Chemical”) announces that it has succeeded part of the Cefixime business from Astellas Pharma, Inc. (Head Office: Chuo-Ku, Tokyo; President & CEO: Kenji Yasukawa, Ph.D.; hereinafter “Astellas Pharma”). Through this agreement, Otsuka Chemical acquires the business of Cefixime from Astellas Pharma to supply the API (Active Pharmaceuti


Leave Comment


Your Name *
Your Email *
Your Website

Comment *